000 01596 a2200433 4500
005 20250517033052.0
264 0 _c20160210
008 201602s 0 0 eng d
022 _a2151-4658
024 7 _a10.1002/acr.22613
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFoeldvari, Ivan
245 0 0 _aUveitis Events During Adalimumab, Etanercept, and Methotrexate Therapy in Juvenile Idiopathic Arthritis: Data From the Biologics in Pediatric Rheumatology Registry.
_h[electronic resource]
260 _bArthritis care & research
_cNov 2015
300 _a1529-35 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdalimumab
_xadministration & dosage
650 0 4 _aAdolescent
650 0 4 _aAntirheumatic Agents
_xadministration & dosage
650 0 4 _aArthritis, Juvenile
_xdiagnosis
650 0 4 _aBiological Products
_xadministration & dosage
650 0 4 _aChild
650 0 4 _aCohort Studies
650 0 4 _aDrug Therapy, Combination
650 0 4 _aEtanercept
_xadministration & dosage
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMethotrexate
_xadministration & dosage
650 0 4 _aRegistries
650 0 4 _aRheumatology
_xmethods
650 0 4 _aStatistics as Topic
_xmethods
650 0 4 _aTumor Necrosis Factor-alpha
_xantagonists & inhibitors
650 0 4 _aUveitis
_xchemically induced
700 1 _aBecker, Ingrid
700 1 _aHorneff, Gerd
773 0 _tArthritis care & research
_gvol. 67
_gno. 11
_gp. 1529-35
856 4 0 _uhttps://doi.org/10.1002/acr.22613
_zAvailable from publisher's website
999 _c24915020
_d24915020